The global Pain Management Devices Market size is expected to reach USD 9.3 billion by 2026 registering a CAGR of 7.6%, according to a new study by Grand View Research, Inc. Rising prevalence of diabetes, coupled with increasing geriatric population base across the globe, is the major factor augmenting the growth of this market. Preference for pain management devices over oral drugs and surgical interventions is also likely to be a high impact rendering driver for the market over the forecast period.
The
global market is expected to witness strong growth as a result of various
technological advancements in this field. These advancements include the advent
of products such as electrode-based wearable automatic transcutaneous
electrical nerve stimulators, which provide peripheral pain management in a
60-minute run cycle.
Neurostimulation
devices are more efficient than traditional methods as they show a sustained
reduction in pain. Additionally, traditional therapy involves intake of
medicines that could result in many adverse effects. Such equipment is widely
used to manage neuropathic pain as spinal cord stimulators yield the best
results. Moreover, these devices offer a customized level of stimulation
depending on the activities undertaken by the patient in a day.
North
America was the largest regional market in 2018 and held around half of the
global revenue owing to the increased number of people affiliated with pain and
thereby requiring management devices. The region is expected to maintain its
dominance throughout the forecast years on account of presence of sophisticated
healthcare infrastructure and rising adoption of advanced equipment by
healthcare professionals and patients over conventional treatment therapies.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/pain-management-devices-market
Further key findings from the study suggest:
- By product,
neurostimulation led the global market in 2018, accounting for a revenue
share of more than 60.0%. These devices have higher preference over
traditional technologies due to their higher efficiency in terms of
providing relief for a longer duration
- The
radiofrequency ablation segment is expected to witness the highest CAGR
from 2019 to 2026. Rising usage of these devices to cure cancer is the
major factor driving their adoption. Long-term relief from cancer pain is
also a high impact rendering driver for this segment
- Key
companies in the global pain management devices market include B Braun
Melsungen AG.; Baxter International, Inc.; Boston Scientific Corp.; Codman
and Shurtleff; DJO Global LLC; Pfizer, Inc.; Medtronic Plc; Smiths
Medical; Stryker Corp.; and St. Jude Medica.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment